Bringing care and compassion to childhood cancer patients. Imagine walking into a room filled with strangers to deliver news you know will impact their lives for years to come. One doctor at the Children’s Hospital of Georgia wants to make sure a cancer diagnosis becomes just a memory in a long, happy and healthy life. After all, that’s the way he chooses to live his life each day.
“I was 14 years of age when I learned I had B-cell intense lymphoblastic leukemia,” said Dr. Eric Ring, aide educator of pediatric hematology and oncology. “I remember everything about that day. I recall who was in the live with me, where they were sitting, even that my primary care physician missed a spot shaving that morning.”
It was the beginning of Ring’s first year when he was analyzed. He remained at home the primary day since he wasn’t feeling admirably. On the subsequent day, he was in class. While he said he despite everything didn’t feel sound, he realized he needed to go to class. On the third day, he went to the specialist. That visit finished his school year before it truly began.
“The thing I was generally worried about were the things I was intending to do later in the year,” Ring said. “I needed to spend time with my companions, go angling and chasing with my family. I was concerned I wouldn’t have the option to do those things.”
Ring spent his first year experiencing exceptional chemotherapy in any event once per week to treat his leukemia. For the following two years, Ring experienced an upkeep chemotherapy routine. It implied two years of oral chemotherapy, alongside excursions to the center to check his blood tallies. Month to month during those two years, Ring got chemotherapy through a spinal tap or an IV line.
While a malignant growth finding as a youngster or adolescent can assume a job in an individual’s vocation way, Ring settled on his decision through a progression of choices during his time in school, clinical school and residency.
“I was interested in science class,” he said. “It was the first occasion when someone disclosed to me how things functioned. At that point, I found a good pace and I figured out how things should function and how everything could turn out badly.”
Today, Ring fills in as a pediatric hematology/oncology specialist at the Children’s Hospital of Georgia. For certain specialists, enduring malignancy would be a story they would decide to impart to their pediatric patients and the youngster’s folks. Be that as it may, Ring settled on a choice not to talk about his malignancy straightforwardly.
“I need my patients to consider me to be their primary care physician first,” he said. “I prepared for a long time to give the most ideal consideration to these youngsters. I need them to believe that I’m settling on cool headed choices dependent on my clinical information, not my own encounters.”
Ring approaches chemotherapy and immunotherapy medications for his patients as choices that have a great deal of intensity. He said it’s significant for specialists to know the various kinds of prescriptions out there and how to endorse them securely and successfully. He relates it to a similar encounter levels you may discover at vehicle fix shops.
“A general repairman can fix generally customary, ordinary autos out and about,” he said. “Be that as it may, fixing an intriguing vehicle requires an additional arrangement of abilities and more information about how those fascinating autos work.”
At the point when he’s not treating general malignant growth and blood issue patients, Ring functions as a co-agent with Dr. Ted Johnson and Dr. David Munn in the Pediatric Immunotherapy Program. He helps Johnson and Munn with creating and executing exploratory clinical preliminaries utilizing immunotherapy for kids with backslid malignant growth. As of now, they are utilizing an exploratory medication, Indoximod, alongside chemotherapy for youngsters with backslid or dynamic mind tumors. Indoximod permits the patient’s own insusceptible framework to more readily battle their illness. They trust that the work they are doing now will one day improve fix rates for youngsters with cerebrum tumors.
“In the event that there’s one thing I would need others to know, it’s that I don’t consider my very own malignant growth experience that regularly any longer,” Ring said. “I have a similar objective for every one of the patients I treat. I need them to recall these critical occasions, however I don’t need them to characterize the remainder of their lives.”